Bicycle Therapeutics PLC
NASDAQ:BCYC
Bicycle Therapeutics PLC
Cash from Investing Activities
Bicycle Therapeutics PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$2.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Exscientia PLC
NASDAQ:EXAI
|
Cash from Investing Activities
-£21.5m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
See Also
What is Bicycle Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
-2.9m
USD
Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Cash from Investing Activities amounts to -2.9m USD.
What is Bicycle Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-17%
Over the last year, the Cash from Investing Activities growth was 82%. The average annual Cash from Investing Activities growth rates for Bicycle Therapeutics PLC have been -25% over the past three years , -17% over the past five years .